Coloplast A Stock Performance
| CLPBY Stock | USD 8.60 0.07 0.82% |
The firm shows a Beta (market volatility) of 0.72, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Coloplast's returns are expected to increase less than the market. However, during the bear market, the loss of holding Coloplast is expected to be smaller as well. At this point, Coloplast A has a negative expected return of -0.0605%. Please make sure to confirm Coloplast's value at risk, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Coloplast A performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Coloplast A has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Coloplast is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 448 M | |
| Total Cashflows From Investing Activities | -11.8 B |
Coloplast |
Coloplast Relative Risk vs. Return Landscape
If you would invest 898.00 in Coloplast A on October 29, 2025 and sell it today you would lose (38.00) from holding Coloplast A or give up 4.23% of portfolio value over 90 days. Coloplast A is currently producing negative expected returns and takes up 1.446% volatility of returns over 90 trading days. Put another way, 12% of traded pink sheets are less volatile than Coloplast, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Coloplast Target Price Odds to finish over Current Price
The tendency of Coloplast Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 8.60 | 90 days | 8.60 | about 79.34 |
Based on a normal probability distribution, the odds of Coloplast to move above the current price in 90 days from now is about 79.34 (This Coloplast A probability density function shows the probability of Coloplast Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Coloplast has a beta of 0.72 suggesting as returns on the market go up, Coloplast average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Coloplast A will be expected to be much smaller as well. Additionally Coloplast A has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Coloplast Price Density |
| Price |
Predictive Modules for Coloplast
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Coloplast A. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Coloplast Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Coloplast is not an exception. The market had few large corrections towards the Coloplast's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Coloplast A, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Coloplast within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.13 | |
β | Beta against Dow Jones | 0.72 | |
σ | Overall volatility | 0.22 | |
Ir | Information ratio | -0.1 |
Coloplast Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Coloplast for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Coloplast A can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Coloplast A generated a negative expected return over the last 90 days |
Coloplast Fundamentals Growth
Coloplast Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Coloplast, and Coloplast fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Coloplast Pink Sheet performance.
| Return On Equity | 0.75 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 28.84 B | |||
| Shares Outstanding | 2.12 B | |||
| Price To Earning | 37.95 X | |||
| Price To Book | 22.46 X | |||
| Price To Sales | 1.13 X | |||
| Revenue | 22.58 B | |||
| EBITDA | 7.23 B | |||
| Cash And Equivalents | 854 M | |||
| Cash Per Share | 0.40 X | |||
| Total Debt | 16.36 B | |||
| Debt To Equity | 2.83 % | |||
| Book Value Per Share | 2.78 X | |||
| Cash Flow From Operations | 5.1 B | |||
| Earnings Per Share | 0.31 X | |||
| Total Asset | 34.96 B | |||
About Coloplast Performance
Evaluating Coloplast's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Coloplast has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Coloplast has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.Things to note about Coloplast A performance evaluation
Checking the ongoing alerts about Coloplast for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Coloplast A help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Coloplast A generated a negative expected return over the last 90 days |
- Analyzing Coloplast's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Coloplast's stock is overvalued or undervalued compared to its peers.
- Examining Coloplast's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Coloplast's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Coloplast's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Coloplast's pink sheet. These opinions can provide insight into Coloplast's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Coloplast Pink Sheet Analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.